ATNX
$4.81
Athenex
($.57)
(10.59%)
ATNX
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($0.37)
Revenue:  N/A
Monday
May 31
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ATNX reports earnings?
Beat
Meet
Miss

Where is ATNX's stock price going from here?
Up
Flat
Down
Stock chart of ATNX
Analysts
Summary of analysts' recommendations for ATNX
Score
Grade
Pivots
Resistance
$6.05
$5.74
$5.28

$4.97

Support
$4.51
$4.20
$3.74
Tweet
Growth
Description
Athenex, Inc. is a clinical stage biopharmaceutical company. It engaged in the discovery and development of drugs for the treatment of cancer. The company's platform including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. It operates primarily in Buffalo and Clarence, New York, Cranford, New Jersey, Houston, Texas, Chicago, Illinois, Hong Kong and Taipei Taiwan. Athenex, Inc. is based in Buffalo, United States.